Q1 2019 HTG Molecular Diagnostics Inc Earnings Call Transcript
Good day, and welcome to the HTG Molecular Diagnostics, Inc. First Quarter 2019 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Monique Kosse. Please go ahead, ma'am.
Thank you, Dory. Earlier today, HTG released financial results for the quarter ended March 31, 2019.
Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws, including potential go-forward decisions by PDP customers, recent product launch expected instrument placements in Europe, expansion of the company's relationship with Illumina, product development efforts, possible additional collaborations with pharma customers and revenue expectations for the full year 2019.
These forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond HTG's control that may cause HTG's actual circumstances, events or results to differ materially from
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |